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Abstract: 
Ingesting phenolic phytochemicals in many plant products may promote health, but the effects of 
phenolic phytochemicals at the cellular level have not been fully examined. Thus, it was determined if the tea 
phenolic phytochemical, epigallocatechin gallate (EGCG), protects U937 human pro-monocytic cells against 
the nitrogen free radical, nitric oxide (•NO). Cells were incubated for 4-6 h with 500 µM S-nitrosoglutathione 
(GSNO), which generates •NO, but this did not induce single-strand breaks in DNA. Nevertheless, 82 ± 4% of 
GSNO-treated cells, compared to only 39 ± 1% of untreated cells, were arrested in the G1-phase of the cell 
cycle. However, dosing the GSNO-treated cells with 9, 14, or 18 µg/ml of EGCG resulted in only 74 ± 8%, 66 ± 
1%, and 43 ± 3% of the cells, respectively, in the G1-phase. Exposing cells to GSNO also resulted in the 
emergence of a sub-G1 apoptotic cell population numbering 14 ± 3%, but only 5 ± 2%, 5 ± 1%, and 2 ± 0% 
upon dosing of the GSNO-treated cells with 9, 14, and 18 µg/ml of EGCG, respectively. Furthermore, exposing 
cells to GSNO resulted in greater cell surface binding of annexin V-FITC, but binding was 41-89% lower in 
GSNO-treated cells dosed with EGCG. Collectively, these data suggest that •NO or downstream products 
induced cell cycle arrest and apoptosis that was not due to single-strand breaks in DNA, and that EGCG 
scavenged cytotoxic •NO or downstream products, thus reducing the number of cells in a state of cell cycle 
arrest or apoptosis. 
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Article: 
Phenolic phytochemicals are a large class of natural substances that can be found in many edible plant products 
such as fruits, vegetables, herbs, and spices. Because of their diverse chemical structures [Shahidi and 
Wanasundara, 1992], phenolic phytochemicals have many interesting properties. For example, their antioxidant 
activity [Rice-Evans et al., 1995] enables them to effectively scavenge free radicals. As previously 
demonstrated in non-cellular models, phenolic phytochemicals scavenge reactive oxygen species (ROS) such as 
hydroxyl radical (•OH) [Hanasaki et al., 1994], hydrogen peroxide (H2O2) and superoxide anion (O2-) [Cai et 
al., 1997], as well as reactive nitrogen species (RNS) such as nitric oxide (•NO) [van Acker et al., 1995] and 
peroxynitrite (ONOO-) [Haenen et al., 1997]. Because ROS and RNS may be involved in the development of 
numerous chronic degenerative diseases [Halliwell and Gutteridge, 1990], it is critical for optimum health to 
keep ROS and RNS at reasonably low levels by way of antioxidants such as phenolic phytochemicals. 
 
When present in excess, RNS such as •NO can react with DNA [Halliwell, 1999] and other critical cellular 
components. If structural or covalent modification of DNA has been sustained, cells arrest in the G1-phase of 
the cell cycle in an attempt to repair the damaged DNA. If such DNA lesions are irreparable, cells undergo 
                                               
* Grant sponsor: Department of Agriculture/National Research Initiative Competitive Grants Program; Grant number: 9700765. 
programmed cell death or apoptosis. On the other hand, under abnormal conditions such as faulty DNA repair 
[Sancar, 1995] or presence of a defective tumor suppressor gene [Lee et al., 1994], the DNA lesions can give 
rise to mutations that allow cancer cells to evolve. Because •NO-induced damage to DNA could lead eventually 
to mutagenesis and cancer [Halliwell,1994], there is substantial interest in examining free radical scavengers or 
antioxidants that inhibit •NO. 
 
The daily consumption of tea beverage, a food rich in phenolic phytochemicals, is believed to have many 
beneficial effects on health, especially in preventing mutagenesis and carcinogenesis that are associated with 
free radicals. Epidemiological studies link tea beverage drinking to a lower incidence of certain types of cancer 
[Ji et al., 1996; Katiyar and Mukhtar, 1996]. Consumption of tea extract by animals reduced the degree of 
tumorigenesis when they were exposed to chemical carcinogens [Katiyar and Mukhtar, 1996]. In explaining the 
putative cancer chemopreventive effects of tea beverage, its constituent phenolic phytochemicals, particularly 
epigallocatechin gallate (EGCG), have been examined for antioxidant or free radical-scavenging activity and 
antitumorigenic effects. EGCG scavenged •NO reagent [van Acker et al., 1995], as well as inhibited ionizing 
radiation-induced scission of plasmid DNA [Yoshioka et al., 1996] and formation of 8-oxodeoxyguanosine in 
calf thymus DNA exposed to ONOO- [Fiala et al., 1996]. EGCG inhibited stomach tumorigenesis in rodents 
exposed to N-methyl-N'-nitro-N-nitroguanidine [Yamane et al., 1995]. 
 
Most recently, we found that EGCG had the most antioxidant activity of several phenolic phytochemicals 
tested, as evaluated by the capacity of the test substances to scavenge the stable free radical, α,α-diphenyl-β-
picrylhydrazyl [Johnson and Loo, 2000]. Moreover, EGCG inhibited oxidative damage to DNA that was 
induced by incubating cells briefly with either H2O2 or ONOO-. However, we did not study if EGCG inhibits 
the possible adverse effect of •NO on DNA and cell viability. Therefore, we determined if •NO damages DNA 
and induces cell cycle arrest and/or apoptosis. Most importantly, we evaluated the efficacy of EGCG to protect 
cells against •NO. 
 
MATERIALS AND METHODS  
 
Materials 
U937 human pro-monocytic cells were purchased from ATCC (Rockville, MD). RPMI 1640 cell culture 
medium and additives, EGCG, camptothecin, propidium iodide (PI), low and normal melting point agarose 
were purchased from Sigma Chemical Co. (St. Louis, MO). S-nitrosoglutathione (GSNO) was purchased from 
Calbiochem (La Jolla, CA). General reagents and frosted microscope slides were purchased from Fisher 
Scientific Co. (Pittsburgh, PA). The annexin V-FITC binding assay kit was purchased from PharMingen (San 
Diego, CA). 
 
Cell Culture and Treatment 
U937 cells were grown in RPMI 1640 medium that was supplemented with 10% fetal bovine serum, 1% 
glutamine, 1% penicillin-streptomycin (10,000 U/ml), and 0.2% amphotericin B (250 µg/ml). The cells were 
maintained in a humidified incubator (95% air/5% CO2) set at 37°C. 
 
Cells (5 x 10
5
/ml) were co-treated with 0 or 500 µM GSNO and 0, 20 µM (9 µg/ml), 30 µM (14 µg/ml) or 40 
µM (18 µg/ml) EGCG, and then placed inside the humidified incubator (time point zero). Because GSNO has a 
half-life of several hours and thus generates a steady flux of •NO during the course of incubation [Kroncke and 
Kolb-Bachofen, 1999], the U937 cells receiving the EGCG treatment were dosed with an additional 0, 9, 14, or 
18 µg/ml of EGCG every 2 h throughout the experiment. After 4-6 h of total incubation time, the cells were 
harvested for analysis. In some experiments, camptothecin (1 µg/ml), a known inducer of cell cycle arrest and 
apoptosis [Johnson et al., 1997], was used as a positive control. 
 
Detection of Single-Strand Breaks in Cellular DNA 
To detect DNA damage (in the form of single- strand breaks) in the U937 cells, alkaline microgel 
electrophoresis (i.e., comet assay) was performed under dim light [Singh et al., 1988]. Briefly, after exposure of 
cells (5 x 10
4
) to GSNO for 4 h in the absence and presence of EGCG, the U937 cells were washed and then 
resuspended in 1% low melting point agarose dissolved in phosphate-buffered saline (PBS). Then, 75 µl of this 
mixture was pipetted onto a frosted microscope slide that had been pre-coated with 75 µl of 1% normal melting 
point agarose dissolved in PBS. After immediately placing a glass cover slip over the slide, the agarose/cell 
mixture was allowed to congeal on ice for 10 min. After removing the cover slip, the slide was immersed in ice-
cold lysis solution (2.5 M NaCl, 100 mM disodium EDTA, 10 mM Tris, 10% DMSO, and 1% Triton X-100) for 
1 h. Next, slides were placed in a submarine gel electrophoresis unit containing 300 mM NaOH and 1 mM 
EDTA, pH 13, for 40 min, before being electrophoresed at 20 V (300 mA) for 20 min. Following 
electrophoresis, the slides were immersed in a neutralizing buffer (0.4 M Tris-HCl, pH 7.5), before applying 60 
µl of 2 µg/ml ethidium bromide to stain the DNA. 
 
Slides were viewed on an Olympus IX-70 inverted fluorescence microscope. Each of 50 randomly-selected 
nucleoids per slide was scored on an arbitrary scale of 0-4 (i.e., ranging from no damage to extensive damage of 
DNA), which is a reflection of the comet tail span. Hence, the data are reported as the comet score with a range 
of 0-200. Despite being subjective, this way of scoring comets compares acceptably with computer imaging 
analysis [McCarthy et al., 1997]. 
 
DNA Cell Cycle Analysis 
To quantitatively determine the distribution of cells in the cell cycle, flow cytometric analysis of cellular DNA 
content was performed [Gong et al., 1994]. After exposure to GNSO for 6 h in the absence and presence of 
EGCG, U937 cells (2 x 10
6
) were washed twice with ice-cold PBS (Ca
2+
/Mg
+
-free). The cells were then fixed 
with 2 ml of ice-cold 70% ethanol and incubated overnight at —20°C. Next, the cells were washed with the ice-
cold PBS to remove the ethanol. The cell pellet was resuspended in 500 µl of the PBS, mixed with 1 ml of DNA 
extraction buffer (0.2 M Na2PO4 and 0.1 M citric acid, pH 7.8), and incubated at room temperature for 5 min. 
After centrifugation at 300g for 8 min, the cell pellet was resuspended in 1 ml of a solution containing 0.5 
µg/ml RNase and 0.08 mg/ml PI for subsequent incubation in the dark at room temperature for 30 min. The PI 
fluorescence associated with DNA was measured on a Becton-Dickinson FACSCalibur flow cytometer with 
excitation at 488 nm and emission at 585 nm using the FL2 channel. The percentage of nuclei in each of the cell 
cycle phases (G1, S, G2/M) was calculated from the standard DNA histograms. Additionally, a sub-G1 peak on 
the DNA histograms was interpreted as an apoptotic cell population having a lowered DNA content 
[Darzynkiewicz et al., 1992]. 
 
Examination of the Cells for Morphological Signs of Apoptosis 
To assess U937 cells for morphological signs of apoptosis, i.e., membrane blebbing and formation of apoptotic 
bodies [Samali et al., 1996], the cells were examined on a phase-contrast light microscope. After exposure to 
GSNO for 6 h in the absence and presence of EGCG, 200 randomly selected cells per treatment were scored for 
presence of the morphological markers of apoptosis. The percentage of apoptotic cells was then calculated from 
the total number of cells scored. 
 
Determination of Annexin V-FITC Binding as Another Marker of Apoptosis 
In the beginning stages of apoptosis, there is translocation of phosphatidylserine (PS) from the inner to outer 
leaflet of the plasma membrane. This apoptotic event was determined with an annexin V-FITC binding assay kit 
following the manufacturer's instructions. The annexin V-FITC binds to the PS, thus giving a fluorescence 
signature to apoptotic cells [Zhang et al., 1997]. 
 
After 6 h of exposure to GSNO in the absence or presence of EGCG, U937 cells (1 x 10
6
) were washed twice 
with ice-cold PBS. The cell pellet was resuspended in 1 ml of 1X binding buffer (10 mM Hepes/NaOH, pH 7.4, 
140 mM NaCl, and 2.5 mM CaCl2). To 100 µl of this cell suspension, 5 µl of Annexin V-FITC and 10 µl of PI 
(0.5 µg) were added and mixed. After 15 min of incubation in the dark, 400 µl of 1X binding buffer were added 
and mixed. The annexin V-FITC/PI fluorescence was measured on the FACSCalibur flow cytometer, using the 
FL1 and FL2 channels, respectively. 
 
Statistical Analysis of Data 
Where applicable, data were analyzed by analysis of variance (ANOVA) and Fisher's Protected Least 
Significant Differences Test using a commercial computer program (SYS STAT, Chicago, IL). 
 
RESULTS 
 
As shown in Figure 1, exposing U937 cells to GSNO (or more precisely, the •NO generated from GSNO) for 4 
h did not induce single-strand breaks in DNA, as assessed by the comet assay. The comet scores for GSNO-
treated and untreated cells were 20 ± 7 and 15 ± 3, respectively. Moreover, no increase in DNA damage was 
detected in cells that were exposed to GSNO for shorter time periods (data not shown). In contrast, EGCG, 
which was anticipated only to 
 
 
 
inhibit any GSNO-induced DNA damage, actually promoted DNA damage in a concentration-dependent 
manner. Dosing U937 cells with 9, 14, and 18 µg/ml of EGCG resulted in comet scores of 36 ± 6, 162 ± 2, and 
188 ± 8, respectively. By interpreting other data in Figure 1 from a totally different perspective, it seems that 
500 µM GSNO inhibited the DNA damage that was induced by dosing the cells with 9, 14, or 18 µg/ml of 
EGCG. 
 
Although EGCG by itself induced DNA damage in U937 cells, cell cycle arrest was not detected. The 
percentages of cells from EGCG-treated and untreated control samples in the G1-phase (Fig. 2) and G2/M-phase 
(Fig. 3) of the cell cycle were not different. Moreover, EGCG treatment did not affect the percentage of cells in 
the S-phase (Fig. 4). 
 
In contrast, despite not increasing DNA single-strand breaks in U937 cells, GSNO caused cell cycle arrest. 
There was 82 ± 4% of GSNO-treated cells, compared to only 39 ± 1% of untreated control cells, present in the 
G1- phase (Fig. 2). Accordingly, only 11 ± 4% of GSNO-treated cells, compared to 44 ± 1% of untreated 
control cells, were found in the S-phase (Fig. 4). 
 
 
 
 
As further revealed by the data, co-treating or dosing the GSNO-treated cells with EGCG resulted in a lower 
percentage of cells in the G1-phase (Fig. 2) and a higher percentage of cells in the S-phase (Fig. 4). Doses of 9 
and 14 µg/ ml of EGCG had only slight effects, but 18 µg/ ml of EGCG had a very notable effect because the 
percentage of cells in the G1-phase (43 ± 3%) and S-phase (49 ± 2%) were similar to their respective control 
values. Additionally, a distinct sub-G1 peak, indicative of an apoptotic cell population with hypodiploid DNA 
content, was observed on the flow cytometric DNA histograms for U937 cells that were exposed to GSNO. 
When translated into numerical values, GSNO-treated cells had a sub-G1 cell population of 14 ± 3% compared 
to only 1 ± 0% in control cells (Fig. 5). Treatment of cells with EGCG alone did not increase the sub-G1 cell 
population over the control. However, dosing U937 cells with 9,14, or 18 µg/ml of EGCG after GSNO 
treatment resulted in sub-G1 populations of 5 ± 2%, 5 ± 1%, and 2 ± 0%, respectively. 
 
To confirm the ability of EGCG to protect U937 cells against the cytotoxic effects of GSNO, other markers of 
apoptosis such as cell morphological changes and annexin V-FITC binding were considered as well. In 
examining cells for morphological signs of apoptosis (Fig. 6), membrane blebbing and presence of apoptotic 
bodies (Fig. 7) were observed in 30 ± 4% of the U937 cells exposed to GSNO, compared to only 4 ± 1% in 
control cells. EGCG alone did not produce such morphological changes, and again protected the cells against 
the cytotoxic effect of GSNO. Only 3 ± 1%, 6 ± 2%, and 6 ± 1% of the GSNO-treated cells that were dosed 
with 9, 14, and 18 µg/ml of EGCG, respectively, showed the morphological signs of apoptosis. 
 
Annexin V-FITC binding data generated by flow cytometry (Fig. 8) show that only 3 ± 0% of control cells 
bound annexin V-FITC, whereas 48 ± 3% of GSNO-treated cells bound annexin V-FITC, as exemplified in 
Figure 9. Treating cells with EGCG alone did not increase the percentage of cells binding annexin V-FITC. 
However, dosing U937 cells with 9 or 14 µg/ml of EGCG resulted in a lower percentage of cells binding 
annexin V-FITC (28 ± 6% and 23 ± 4%, respectively). Dosing GSNO-treated cells with 18 µg/ml of EGCG 
resulted in only 5 ± 1% of the cells binding annexin V-FITC. 
 
DISCUSSION 
 
The basis for the current study emanated from our most recent but limited study [Johnson and Loo, 2000], 
where it is reported that EGCG inhibited both H2O2-induced and ONOO-- induced oxidative damage to cellular 
DNA. To expand this previous work, we focused on •NO in studying whether this nitrogen free radical could 
not only induce DNA damage but also cell cycle arrest and apoptosis. We simultaneously evaluated the ability 
of EGCG to inhibit the adverse effects of •NO. We originally hypothesized that •NO would cause single-strand 
breaks in DNA. Moreover, we hypothesized that if EGCG scavenged •NO and prevented the structural damage 
to DNA, cell cycle arrest and/or apoptosis would not occur. In other words, if EGCG decreased the number of 
cells in a state of cell cycle arrest or apoptosis when they are exposed to •NO, this would more likely mean that 
EGCG inhibited structural damage to DNA rather than EGCG interfering with steps or components of the cell 
cycle and apoptosis. 
 
To expose them to •NO, U937 cells were incubated at 37°C with GSNO. During incubation, GSNO 
spontaneously decomposes to produce •NO for several hours [Kroncke and Kolb-Bachofen, 1999]. After readily 
diffusing across lipid bilayers of cell membranes [Subczynski et al., 1996], •NO travels freely within the cell 
and reacts with other molecules to generate additional types of RNS. For example, an important reaction of •NO 
at physiological pH is its oxidation by molecular oxygen to yield nitrous anhydride (N2O3) [Marletta, 1988; 
Lewis et al., 1995]. Another major fate of •NO is its reaction with O2- to yield ONOO- [Huie and 
Padmaja,1993]. Thus, it is possible that any adverse effects of GSNO-derived •NO may be attributed partly to 
N2O3, ONOO-, or perhaps other downstream active products. Both N2O3 and ONOO- are potent nitrosation 
agents, capable of chemically modifying the structure of DNA and causing temporary single-strand breaks in 
DNA [Burney et al., 1999]. That is, nitrosylation of primary amines on the purine and pyrimidine bases of DNA 
leads to their deamination via diazonium ion formation. Hydrolysis of the diazonium ion completes the reaction 
sequence, resulting in the replacement of an amino group by a hydroxyl group. Such chemically modified sites 
on DNA are cleaved by DNA glycosylases, giving rise to temporary single-strand breaks as nucleotide excision 
repair occurs [Yu et al., 1999]. Furthermore, ONOO- can cause oxidative damage to DNA. Upon protonation, 
ONOO- is transformed into peroxynitrous acid that can exist as an excited intermediate having hydroxyl 
radical-like oxidative potential [Aust and Eveleigh, 1999]. Indeed, ONOO- may actually generate •OH 
[Beckman et al., 1990] that attacks the deoxyribose moiety of DNA in causing stand breaks [Hiramoto et al., 
1996]. 
 
It has been reported [Green et al., 1996] that GSNO can cause single-strand breaks in cellular DNA, as assessed 
by the comet assay. As a discrepancy, we were unable to detect an increase in DNA single-strand breaks in 
U937 cells exposed to GSNO for 4 h or less. While •NO nitrosylatively modifies the structure of DNA [Burney 
et al., 1999] and suppresses DNA synthesis by inhibiting ribonucleotide reductase [Lepoivre et al., 1991], it is 
inconclusive if •NO directly causes strand breaks in DNA [Nguyen et al., 1992; Tamir et al., 1996]. In contrast, 
exposing Jurkat T-lymphocytes for 30 min to 3-morpholinosydnonimine (SIN-1), which thermally decomposes 
to generate ONOO-, resulted in a marked increase in DNA single-strand breaks [Johnson and Loo, 
 
 
2000]. Therefore, it seems that ONOO- was not generated in sufficient amounts, from the reaction between 
GSNO-derived •NO and existing O2-, to significantly increase DNA single- strand breaks when U937 cells 
were exposed to GSNO. Instead of GSNO-derived •NO causing direct DNA damage, it seems more probable 
that the •NO generated from GSNO immediately reacted to form N2O3 or perhaps other derivatives, which then 
nitrosylatively modify the structure of DNA. Hence, it is suggested that •NO mediated its cellular effects by 
nitrosylatively modifying the chemical structure of DNA rather than by inducing direct single-strand breaks in 
DNA as •OH is capable of doing [Hiramoto et al., 1996]. 
 
Cells that sustain extensive covalent modification or damage to DNA typically arrest in the G1-phase of the cell 
cycle, thus stopping DNA synthesis [Canman et al., 1994]. During this time, the cells attempt to repair the DNA 
before progressing into the S-phase. Apparently, the probable nitrosylative modification of DNA caused by 
GSNO, or its degradative products, in U937 cells was extensive enough to induce cell cycle arrest. An increased 
number of cells were found arrested in the G1-phase. Dosing of GSNO-treated U937 cells with EGCG reduced 
the number of cells in G1-phase arrest. EGCG likely scavenged the •NO or other GSNO-derived active 
products, thereby negating structural modification of DNA that may have initiated the cell cycle arrest. In 
support of this view, it is well established that phenolic phytochemicals like EGCG scavenge •NO [van Acker et 
al., 1995] and ONOO- [Haenen et al., 1997]. Pre-incubating DNA bases with either EGCG or closely related 
substances (catechin and epicatechin) inhibited the formation of hypoxanthine and xanthine that was caused 
 
 
by the acidic nitrite-dependent deamination of adenine and guanine, respectively [Oldreive et al., 1998]. In 
another relevant study, EGCG inhibited ONOO--induced formation of 8-oxodeoxyguanosine in calf thymus 
DNA [Fiala et al., 1996]. 
 
Besides affecting DNA directly, it is possible that the •NO derived from GSNO also had other effects that 
promoted cell cycle arrest in the U937 cells. •NO inhibits iron-sulfur proteins such as ribonucleotide reductase 
[Lepoivre et al.,1991], an enzyme that catalyzes biosynthesis of the deoxynucleotide building blocks of DNA. 
Hence, a lowered DNA content in cells might also contribute to the initiation of cell cycle arrest. Moreover, 
•NO inhibits numerous sulfhydryl enzymes, such as glyceraldehyde-3- phosphate dehydrogenase [Padgett and 
Whorton, 1997]. Inhibition of this specific enzyme in glycolysis could limit the amount of energy needed by 
cells to synthesize DNA. 
 
In any event, exposing U937 cells to GSNO led eventually to apoptosis, which was evaluated by examining 
several standard markers. Flow cytometric analysis of GSNO-treated cells revealed a substantial sub-G1 peak on 
the DNA cell cycle histograms, indicating a population of apoptotic cells with less DNA content due to the 
action of endonucleases that fragment the DNA [Enari et al., 1998]. Upon microscopic examination, membrane 
blebbing and small apoptotic bodies were seen in GSNO-treated cell samples. Furthermore, exposing U937 
cells to GSNO resulted in a higher number of the cells binding annexin V-FITC. These findings are consistent 
with other research [Brockhaus and Brune, 1998] that additionally reported the activation of caspases, which are 
cysteine proteases that 
 
 
initiate the execution phase of apoptosis [Wilson, 1998]. In agreement with its ability to reduce the number of 
GSNO-treated cells in G1-phase arrest, EGCG also reduced the number of GSNO-treated cells undergoing 
apoptosis. In other words, dosing GSNO-treated cells with EGCG eliminated the sub-G1 peak appearing on the 
DNA cell cycle histograms, reduced the number of cells binding annexin V-FITC, and also prevented 
membrane blebbing and formation of apoptotic bodies. 
 
The mechanism by which EGCG lowered the numbers of GSNO-treated U937 cells in a state of either cell 
cycle arrest or apoptosis can be deduced. In the presence of certain substances (e.g., GSNO) that can generate 
RNS, EGCG has antioxidant or radical scavenging effects. That is, phenolic phytochemicals such as EGCG 
scavenge both •NO [van Acker et al., 1995] and ONOO- [Haenen et al., 1997]. Therefore, in addition to 
scavenging any ROS present, EGCG may have worked largely by scavenging the •NO produced from GSNO 
and any ONOO-formed from the reaction of •NO and existing O2-. As such, the phenolic structure of EGCG 
may be nitrosated by the GSNO-derived RNS. There is evidence for the nitrosation of EGCG by ONOO- [Fiala 
et al., 1996]. With the RNS scavenged by the EGCG, DNA would not be attacked, and thus, both cell cycle 
arrest and apoptosis would not occur. 
 
Although EGCG was predicted and shown to counteract the cytotoxic effects of GSNO, EGCG had some 
seemingly contradictory effects. Incubating U937 cells with EGCG alone for 4 h resulted in significant DNA 
damage. While this may seem unusual, it is consistent with data in our most recent study [Johnson and Loo, 
2000], where it is reported that Jurkat T-lymphocytes have increased DNA single-strand breaks after being 
incubated with either EGCG or quercetin. Furthermore, other studies have established that phenolic 
phytochemicals can actually induce DNA single-strand breaks as determined by the comet assay. For instance, 
increased DNA single-strand breaks were found in Caco-2 colonic adenocarcinoma, HepG2 hepatoma, and 
HeLa cervical carcinoma epithelilial cells when these cell lines were incubated with either quercetin, myricetin, 
or silymarin [Duthie et al., 1997]. 
 
The pro-oxidant effects of phenolic phytochemicals appear to be due to the presence of metal ions, which can 
facilitate the formation of ROS [Halliwell and Gutteridge, 1990]. For instance, quercetin induced DNA damage 
in isolated rat liver nuclei in the presence of iron or copper [Sahu and Washington, 1991]. Both EGCG and 
quercetin induced strand breaks in plasmid DNA, but this damage was prevented when the metal chelator, 
diethylenetriamine pentaacetic acid, was present during incubation [Ohshima et al., 1998]. Considering that cell 
culture media contain metal ions and the recent report [Long et al., 2000] that adding EGCG to cell culture 
media results in the generation of H2O2, the DNA damage induced by EGCG could be caused by hydroxyl 
radicals, that form when H2O2 reacts with metal ions [Halliwell and Gutteridge, 1990]. 
 
In light of the above discussion, it seems that EGCG can have either antioxidant or pro-oxidant effects on DNA 
in U937 cells depending on the experimental conditions. The capacity of phenolic phytochemicals like EGCG 
to exert such opposite effects has been demonstrated by others as well [Duthie et al., 1997; Aherne and O'Brien, 
1999]. This would explain why EGCG protected the cells against GSNO-mediated apoptosis on the one hand, 
but induced DNA strand breaks on the other hand. More specifically, in the presence of pro-oxidants or 
substances such as GSNO that generate free radicals, EGCG is probably a free radical scavenger. As such, 
EGCG was able to scavenge GSNO-derived •NO or other active products that could have caused structural 
modification of DNA (not to be confused with single-strand breaks) or other adverse effects leading to the 
induction of apoptosis. As a result of reducing the number of GSNO-treated U937 cells undergoing apoptosis, 
EGCG protected the cells so that they remained in cell cycle progression as indicated by the higher number of 
cells in the S- phase compared to U937 cells not fortified with EGCG prior to GSNO exposure. 
 
In striking contrast, in the absence of any added pro-oxidants but the presence of trace amounts of metal ions in 
cultures of U937 cells, EGCG is probably a pro-oxidant or can promote the formation of free radicals. As such, 
EGCG was able to cause single-strand breaks in DNA although apparently not to an extent sufficient to initiate 
apoptosis. Taken together, these findings suggest that the relatively low concentrations of EGCG (20-30 µM) 
did not induce DNA single-strand breaks in U937 cells when GSNO (500 µM) was also present, as supported 
by the data in Figure 1. In interpreting these data from a completely different perspective, an unexpected effect 
of GSNO in EGCG-treated U937 cells can be addressed. Apparently, by donating •NO to react with EGCG, 
GSNO inhibited induction of DNA single-strand breaks caused by EGCG. It is known that under certain 
conditions •NO has antioxidant effects. For example, •NO can protect cells against the cytotoxic effects of H2O2 
[Wink et al., 1999] and can inhibit the oxidation of lipoproteins [Goss et al., 1999]. Lastly, our findings suggest 
that DNA damage (single-strand breaks) was not the cellular event that triggered apoptosis in GSNO-treated 
U937 cells. Some other triggering event (e.g., perhaps structural or covalent modification of DNA) was 
responsible, and EGCG was able to negate it. 
 
As already discussed, the DNA damage caused by EGCG in U937 cells was apparently not sufficient to trigger 
either cell cycle arrest or apoptosis under our experimental conditions. In contrast, using some other cell lines 
and different experimental conditions, EGCG induced G1-phase arrest [Liang et al., 1999], inhibited DNA 
synthesis or the number of cells in the S-phase [Otsuka et al., 1998], and induced G2/M arrest [Okabe et al., 
1999]. Furthermore, EGCG induced apoptosis in fibroblasts [Chen et al., 1998] and three different prostate 
cancer cell lines [Paschka et al., 1998]. Other studies have reported cell cycle arrest or apoptosis in other types 
of cells incubated either with higher doses of other phenolic phytochemicals or for longer periods of time. 
Along this line, genistein [Spinozzi et al., 1994] and apigenin [Lepley and Pelling,1997] induced cell cycle 
arrest in Jurkat T-lymphocytes and human fibroblast cells, respectively. Additionally, phenolic phytochemicals 
such as genistein [Spinozzi et al., 1994], apigenin and quercetin [Plaumann et al., 1996; Richter et al., 1999], 
fisetin and kaempferol [Richter et al., 1999], and luteolin [Plaumann et al., 1996] induced apoptosis. Hence, 
differences in concentrations of the phenolic phytochemicals, cell lines used, and incubation times may explain 
the discrepancy between our results and that of others. 
 
In conclusion, by likely scavenging GSNO-derived •NO or its downstream products and thus preventing 
structural modification of DNA or possibly other adverse cellular effects, EGCG protected cells against the 
cytotoxic effects of GSNO as indicated by the lower number of GSNO-treated cells in a state of cell cycle arrest 
and apoptosis. 
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